Wang et al. found that CNV of METTL4 could be a prognostic biomarker for soft tissue sarcomas (STS) by potentially influencing mast cell infiltration and DNA methylation (Mo et al., 2021). This evidence concerns the gene METTL4 and soft tissue sarcoma.